These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

341 related items for PubMed ID: 25037497

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. A simple method to identify patients on long-term warfarin who may derive the most benefit from new oral anticoagulants.
    Carrier M, Kimpton M, Wells PS, Langlois N, Kherani S, Le Gal G.
    Blood Coagul Fibrinolysis; 2014 Dec; 25(8):812-5. PubMed ID: 24914740
    [Abstract] [Full Text] [Related]

  • 3. Alternative calculations of individual patient time in therapeutic range while taking warfarin: results from the ROCKET AF trial.
    Singer DE, Hellkamp AS, Yuan Z, Lokhnygina Y, Patel MR, Piccini JP, Hankey GJ, Breithardt G, Halperin JL, Becker RC, Hacke W, Nessel CC, Mahaffey KW, Fox KA, Califf RM, ROCKET AF Investigators.
    J Am Heart Assoc; 2015 Mar 03; 4(3):e001349. PubMed ID: 25736441
    [Abstract] [Full Text] [Related]

  • 4. Is the time in therapeutic range using the ratio of tests equivalent to the Rosendaal method?
    Caldeira D, Cruz I, Morgado G, Stuart B, Gomes AC, Martins C, João I, Pereira H.
    Blood Coagul Fibrinolysis; 2015 Dec 03; 26(8):972-6. PubMed ID: 26083988
    [Abstract] [Full Text] [Related]

  • 5. Evaluation of warfarin management with international normalized ratio self-testing and online remote monitoring and management plus low-dose vitamin k with genomic considerations: a pilot study.
    Bussey HI, Bussey M, Bussey-Smith KL, Frei CR.
    Pharmacotherapy; 2013 Nov 03; 33(11):1136-46. PubMed ID: 24038412
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. A prospective study of an aggressive warfarin dosing algorithm to reach and maintain INR 2 to 3 after heart valve surgery.
    Meijer K, Kim YK, Carter D, Schulman S.
    Thromb Haemost; 2011 Feb 03; 105(2):232-8. PubMed ID: 21173999
    [Abstract] [Full Text] [Related]

  • 8. Determinants of oral anticoagulation control in new warfarin patients: analysis using data from Clinical Practice Research Datalink.
    Macedo AF, Bell J, McCarron C, Conroy R, Richardson J, Scowcroft A, Sunderland T, Rotheram N.
    Thromb Res; 2015 Aug 03; 136(2):250-60. PubMed ID: 26073321
    [Abstract] [Full Text] [Related]

  • 9. Evaluation of a pharmacogenetic-based warfarin dosing algorithm in patients with low time in therapeutic range - study protocol for a randomized controlled trial.
    Marcatto LR, Sacilotto L, Bueno CT, Facin M, Strunz CM, Darrieux FC, Scanavacca MI, Krieger JE, Pereira AC, Santos PC.
    BMC Cardiovasc Disord; 2016 Nov 17; 16(1):224. PubMed ID: 27855643
    [Abstract] [Full Text] [Related]

  • 10. Effect of a simple two-step warfarin dosing algorithm on anticoagulant control as measured by time in therapeutic range: a pilot study.
    Kim YK, Nieuwlaat R, Connolly SJ, Schulman S, Meijer K, Raju N, Kaatz S, Eikelboom JW.
    J Thromb Haemost; 2010 Jan 17; 8(1):101-6. PubMed ID: 19840361
    [Abstract] [Full Text] [Related]

  • 11. Anticoagulation control and cost of monitoring of older patients on chronic warfarin therapy in three settings in North East England.
    Abohelaika S, Kamali F, Avery P, Robinson B, Kesteven P, Wynne H.
    Age Ageing; 2014 Sep 17; 43(5):708-11. PubMed ID: 24947831
    [Abstract] [Full Text] [Related]

  • 12. Prediction of the warfarin maintenance dose after completion of the 10 mg initiation nomogram: do we really need genotyping?
    Le Gal G, Carrier M, Tierney S, Majeed H, Rodger M, Wells PS.
    J Thromb Haemost; 2010 Jan 17; 8(1):90-4. PubMed ID: 19874475
    [Abstract] [Full Text] [Related]

  • 13. Quality of warfarin management in primary care: Determining the stability of international normalized ratios using a nationally representative prospective cohort.
    Liu S, Singer A, McAlister FA, Peeler W, Heran BS, Drummond N, Manca DP, Allan GM, Korownyk C, Kolber MR, Greiver M, Garrison SR.
    Can Fam Physician; 2019 Jun 17; 65(6):416-425. PubMed ID: 31189630
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Quality control of oral anticoagulant therapy in Primary Care in Madrid City, Spain: CHRONOS-TAO study].
    Alonso Roca R, Figueroa Guerrero CA, Mainar de Paz V, Arribas García MP, Sánchez Perruca L, Rodríguez Barrientos R, Casado López M, Pedraza Flechas AM.
    Med Clin (Barc); 2015 Sep 07; 145(5):192-7. PubMed ID: 25433789
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Safety and Efficacy Outcomes of Home and Hospital Warfarin Management Within a Pediatric Anticoagulation Clinic.
    Jones S, McLoughlin S, Piovesan D, Savoia H, Monagle P, Newall F.
    J Pediatr Hematol Oncol; 2016 Apr 07; 38(3):216-20. PubMed ID: 26808370
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Bleeding complications and mortality in warfarin-treated VTE patients, dependence of INR variability and iTTR.
    Sandén P, Renlund H, Svensson PJ, Själander A.
    Thromb Haemost; 2017 Jan 05; 117(1):27-32. PubMed ID: 27652593
    [Abstract] [Full Text] [Related]

  • 20. Variability of INR and its relationship with mortality, stroke, bleeding and hospitalisations in patients with atrial fibrillation.
    Lind M, Fahlén M, Kosiborod M, Eliasson B, Odén A.
    Thromb Res; 2012 Jan 05; 129(1):32-5. PubMed ID: 21851969
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.